MO Mural Oncology plc Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Mural Oncology plc stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was filed on 5 December 2025 (Disposition). Among the most active insiders: Keson-Brookes Maiken. Every trade is openly available.
€203,394
16 ops.
Sell Volume
Buys €29,120 €203,394 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 December 2025
All Executives27 Thresholds0 Prospectus0 Other0
Declarations 27 total
● Chief Executive Officer · Executives · 5 Dec 2025
293,059 shares Ordinary Shares SEC:0001193125-25-308787:0
● Chief Legal Officer · Executives · 5 Dec 2025
68,834 shares Ordinary Shares SEC:0001193125-25-308760:0
● Chief Medical Officer · Executives · 5 Dec 2025
84,727 shares Ordinary Shares SEC:0001193125-25-308745:0
● Chief Financial Officer · Executives · 5 Dec 2025
99,290 shares Ordinary Shares SEC:0001193125-25-308739:0
▼ Chief Financial Officer · Executives · 3 Nov 2025
7,148 shares @ US$2.09 35.7% of flow Ordinary Shares SEC:0001193125-25-274768:0
▼ Chief Medical Officer · Executives · 10 Nov 2025
5,036 shares @ US$2.08 12.3% of flow Ordinary Shares SEC:0001193125-25-274765:0
▼ See Remarks · Executives · 22 Jul 2025
2,572 shares @ US$2.48 21.9% of flow Ordinary Shares SEC:0000950170-25-097949:0
▼ See Remarks · Executives · 18 Jul 2025
2,158 shares @ US$2.48 18.6% of flow Ordinary Shares SEC:0000950170-25-097599:0
▼ Chief Executive Officer · Executives · 7 Jul 2025
12,531 shares @ US$2.432 37.9% of flow Ordinary Shares SEC:0000950170-25-094831:0
◆ See Remarks · Executives · 3 Mar 2025
35,000 shares 0Ordinary Shares SEC:0000950170-25-033769:0
◆ Chief Executive Officer · Executives · 3 Mar 2025
72,275 shares 0Ordinary Shares SEC:0000950170-25-033766:0
◆ Chief Medical Officer · Executives · 3 Mar 2025
35,000 shares 0Ordinary Shares SEC:0000950170-25-033764:0
◆ Chief Financial Officer · Executives · 3 Mar 2025
35,000 shares 0Ordinary Shares SEC:0000950170-25-033761:0
▼ Chief Medical Officer · Executives · 24 Feb 2025
13,186 shares @ US$3.89 75.7% of flow Ordinary Shares SEC:0000950170-25-026609:0
▼ See Remarks · Executives · 23 Dec 2024
2,555 shares @ US$3.27 54.3% of flow Ordinary Shares SEC:0000950170-24-140393:0
▼ Chief Executive Officer · Executives · 17 Dec 2024
2,763 shares @ US$3.40 21.0% of flow Ordinary Shares SEC:0000950170-24-137877:0
▼ Chief Medical Officer · Executives · 7 Nov 2024
5,069 shares @ US$3.33 24.3% of flow Ordinary Shares SEC:0000950170-24-124041:0
▼ Chief Financial Officer · Executives · 31 Oct 2024
7,421 shares @ US$3.41 100.0% of flow Ordinary Shares SEC:0000950170-24-119800:0
▲ Director · Executives · 14 Aug 2024
10,000 shares @ US$3.2071 100.0% of flow Ordinary Shares SEC:0000950170-24-097576:0
Canonical exit: 12 Nov 2024 (T+90) ▼ See Remarks · Executives · 18 Jul 2024
2,157 shares @ US$3.41 45.7% of flow Ordinary Shares SEC:0000950170-24-084569:0
▼ Chief Executive Officer · Executives · 8 Jul 2024
12,531 shares @ US$2.91 79.0% of flow Ordinary Shares SEC:0000950170-24-082244:0
◆ See Remarks · Executives · 1 Mar 2024
16,800 shares 0Ordinary Shares SEC:0000950170-24-024913:0
◆ Chief Executive Officer · Executives · 1 Mar 2024
48,475 shares 0Ordinary Shares SEC:0000950170-24-024968:0
◆ See Remarks · Executives · 14 Dec 2023
29,207 shares 0Ordinary Shares SEC:0000950170-23-071106:0
◆ Chief Medical Officer · Executives · 14 Dec 2023
73,018 shares 0Ordinary Shares SEC:0000950170-23-071113:0
25 of 27 declarations
Load more (2 remaining) About Mural Oncology plc Mural Oncology plc is a biopharmaceutical company focused on developing innovative treatments for cancer. It is listed on NASDAQ under the ticker MURAL.